Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02293408 · ClinicalTrials.gov registry record
Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIB
A clinical trial, sponsored by Alexion Pharmaceuticals.
- Terminated
- Registry status
- 30
- Enrollment target
NCT02293408 is a clinical trial that was terminated before completion, run by Alexion Pharmaceuticals. The registered enrollment target is 30 participants.
The verdict
NCT02293408 was terminated before completion, sponsored by Alexion Pharmaceuticals.
- TERMINATED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The objectives of this study are to describe the clinical and biochemical characteristics and course of disease progression in participants with Mucopolysaccharidosis type IIIB (MPS IIIB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-09-14 |
| Est. Completion | 2017-07-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02293408
The ClinicalTrials.gov registry entry for NCT02293408 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alexion Pharmaceuticals, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02293408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02293408 about?
NCT02293408 is a clinical study titled "Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIB". The objectives of this study are to describe the clinical and biochemical characteristics and course of disease progression in participants with Mucopolysaccharidosis type IIIB (MPS IIIB)
What is the current status of trial NCT02293408?
This trial is currently terminated. The enrollment target is 30 participants. The study started on 2014-09-14. Estimated completion is 2017-07-11.
Who is sponsoring clinical trial NCT02293408?
This trial is sponsored by Alexion Pharmaceuticals, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.